BC Platforms
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
% growth | (8 %) | 4 % | 7 % | 34 % | 16 % | 22 % | 6 % |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | - | ||
* | $10.0m | Series B | |
* | $15.0m | Series C | |
* | $20.0m | Growth Equity VC | |
Total Funding | €40.9m |
Recent News about BC Platforms
EditBC Platforms specializes in genomic data management solutions aimed at advancing precision medicine and research. The company integrates clinical and genetic data to provide actionable insights for healthcare providers, research institutions, and pharmaceutical companies. Operating in the global healthcare and biotechnology markets, BC Platforms employs a subscription-based business model, offering its software as a service (SaaS). Revenue is generated through licensing fees, data analytics services, and partnerships with research organizations. The company serves a diverse clientele, including hospitals, universities, and biotech firms, helping them to leverage big data for improved patient outcomes and innovative research.
Keywords: Genomic data, precision medicine, clinical data, genetic insights, healthcare analytics, biotechnology, SaaS, data integration, research partnerships, patient outcomes.